Using tPA for acute stroke in a rural setting

Neurology

Volumn 68, Issue 4, 2007, Pages 292-294

  Edwards, Lorraine L ^a  

^a Central Nebraska Neurology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ACUTE DISEASE; ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG USE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RURAL AREA; STROKE; TRANSIENT ISCHEMIC ATTACK;

ACUTE DISEASE; CEREBROVASCULAR ACCIDENT; HOSPITALS, RURAL; HUMANS; RETROSPECTIVE STUDIES; RURAL POPULATION; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 33846455399     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000253190.40728.0c     Document Type: Article

References (10)

1. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plaminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
2. Furlan AJ IV. Tissue plaminogen activator for stroke in the community. Stroke 2006;37:281.
3. Bateman BT, Schumacher HC, Boden-Albala B, et al. Factors associated with in-hospital mortality after administration of thrombolysis in acute ischemic stroke patients. Stroke 2006;37:440.
4. Heuschmann PU, Berger K, Misselwitz B, et al. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group. Stroke 2003;34:1106-1113.
5. Qureshi AI, Kirmani JF, Sayed MA, et al. Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke. Neurology 2005;64:2115-2120.
6. Katzan IL, Furlan AJ, Lloyd LE, et al. Use of tissue type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 2000;283:1151-1158.
7. Grotta JC, Burgin WS, El-Mitwalli A, et al. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996-2000. Arch Neurol 2001;58:2009-2013.
8. Nighoghossian N, ed. tPA in daily clinical practice. Stroke 2003;34:1112.
9. Bravata DM, et al. Thrombolysis for acute stroke in routine clinical practice. Arch Intern Med 2002;162:1994-2001.
10. Katzan IL, Sila CA, Furlan AJ. Community use of intravenous tissue Plasminogen activator for acute stroke: results of the Brain Matters Stroke Management Survey. Stroke 2001;32:861-865.